4GE7 image
Entry Detail
PDB ID:
4GE7
Title:
Kynurenine Aminotransferase II Inhibitors
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2012-08-01
Release Date:
2012-11-07
Method Details:
Experimental Method:
Resolution:
2.10 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial
Mutations:K240S, F241G
Chain IDs:A, B
Chain Length:439
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CSO A CYS S-HYDROXYCYSTEINE
Ligand Molecules
Primary Citation
Structure-Based Design of Irreversible Human KAT II Inhibitors: Discovery of New Potency-Enhancing Interactions.
ACS Med Chem Lett 4 37 40 (2013)
PMID: 24900560 DOI: 10.1021/ml300237v

Abstact

A series of aryl hydroxamates recently have been disclosed as irreversible inhibitors of kynurenine amino transferase II (KAT II), an enzyme that may play a role in schizophrenia and other psychiatric and neurological disorders. The utilization of structure-activity relationships (SAR) in conjunction with X-ray crystallography led to the discovery of hydroxamate 4, a disubstituted analogue that has a significant potency enhancement due to a novel interaction with KAT II. The use of k inact/K i to assess potency was critical for understanding the SAR in this series and for identifying compounds with improved pharmacodynamic profiles.

Legend

Protein

Chemical

Disease

Primary Citation of related structures